It’s Fortune magazine, August 2000, Special Investors Issue, Retire Rich
Article: 10 Stocks to Last the Decade
And here’s the list:
| Stock | Ticker | Price | P/E | Comment |
| Broadcom | BRCM | $237 | 255 | Maker of chips used in the next generation of entertainment devices |
| Charles Schwab | SCH | $36 | 56 | Former discount broker that has grown up along with its boomer clients |
| Enron | ENE | $73 | 51 | Biggest online broker for coal, oil, and gas; next up — broadband |
| Genentech | DNA | $150 | 128 | Offers a huge pipeline of promising drugs, plus a topflight sales force |
| Morgan Stanley Dean Witter | MWD | $89 | 18 | Just passed Goldman Sachs as the top M&A firm in the world |
| Nokia | NOK | $54 | 75 | Mobile-phone maker now moving into “smart” appliances |
| Nortel Networks | NT | $77 | 114 | 75% of U.S. Internet Traffic travels through its equipment |
| Oracle | ORCL | $74 | 86 | Onetime database firm that has become an e-commerce must-own |
| Univision | UVN | $113 | 122 | Biggest Spanish-language TV programmer in the country |
| Viacom | VIA | $69 | 96 | Owns a stable of media brands like CBS, MTV, and Paramount Pictures |
Where are they now?:
| Stock | Ticker | Price | P/E | Comment |
| Broadcom | BRCM | $28 | 68 | Stock split in 2006 |
| Charles Schwab | SCHW | $22 | 11 | Delisted from the NYSE, moved to NASDAQ. |
| Enron | ECSPQ | $0.08 | 0.35 | Bankrupt. Trading Over the Counter |
| Genentech | DNA | $70 | 24 | Split twice, once right after the article was written and again in 2004 |
| Morgan Stanley | MS | $47 | 27 | Caught up on mortgage meltdown, bailed out by a Chinese company |
| Nokia | NOK | $29 | 10 | Traded as low as $11 a share |
| Nortel Networks | NT | $8 | - | Fell on hard times immediately following the article. Did 1:10 reverse split in 2006. So you can think of the stock as 80 cents. |
| Oracle | ORCL | $22 | 22 | Split soon after the article. Hit a low of $8. |
| Univision | - | - | - | Taken private at $36 / share |
| Viacom | VIA | $39 | 14 |
Of the ten companies, the only one that would have made money over the past eight years was Genentech. Just roughing it, I’d say you would have lost somewhere between 50% and 75% of your investment on these babies. Nice picks.
